Literature DB >> 2450402

Therapy of chronic myelogenous leukemia: chemotherapy and interferons.

M Talpaz1, H M Kantarjian, R Kurzrock, J Gutterman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2450402

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  8 in total

1.  Characterization of three monoclonal antibodies that recognize the interferon alpha 2 receptor.

Authors:  O R Colamonici; F D'Alessandro; M O Diaz; S A Gregory; L M Neckers; R Nordan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 2.  Clinical evaluation of treatment with interferon.

Authors:  H Strander
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.

Authors:  B Anger; F Porzsolt; R Leichtle; B Heinze; C Bartram; H Heimpel
Journal:  Blut       Date:  1989-06

4.  Immunologic Profile of Patients Suffering from Herpes Simplex Virus (HSV) -Associated Oral Lesions Treated with Natural Human Interferon Alpha (Egiferon).

Authors:  György Kövesi; Katalin Pálóczi; Klára Ónody; Béla Fekete
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

5.  In vivo induction of HLA molecules in patients with myeloproliferative syndrome during IFN alpha treatment.

Authors:  C A Müller; J Walz; R Zinser; H J Bühring; B Steinke; H Schmidt
Journal:  Ann Hematol       Date:  1991-11       Impact factor: 3.673

6.  Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patients.

Authors:  G Pawelec; G Ehninger; H Schmidt; C Müller; H J Bühring; M Reutter; F W Busch
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Confirmation and improvement of Sokal's prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.

Authors: 
Journal:  Ann Hematol       Date:  1991-12       Impact factor: 3.673

8.  The roles of age and sex in the prognosis of chronic leukaemias. A study of 373 cases.

Authors:  B Jaksić; B Vitale; E Hauptmann; A Planinc-Peraica; S Ostojic; R Kusec
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.